Vasopressin inhibits mitogen-activated protein kinases and activated protein-1 in macrophages

Yu-Long Chen1, Ya-Ying Chang2, Ming-Chang Kao2

  • 1Department of Emergency Medicine, Taipei Tzu Chi Hospital, Taipei, Taiwan.

Abstract

Insights

Vasopressin effectively inhibits the upregulation of mitogen-activated protein kinases (MAPKs) and activated protein-1 (AP-1) in macrophages stimulated with lipopolysaccharide (LPS). This finding suggests vasopressin

Area of Science:

  • Immunology
  • Cell Biology
  • Pharmacology

Background:

  • Inflammatory mediator expression is regulated by mitogen-activated protein kinases (MAPKs) and activated protein-1 (AP-1).
  • Vasopressin has demonstrated potential in inhibiting inflammatory mediator upregulation previously.

Purpose of the Study:

  • To investigate whether vasopressin can inhibit the upregulation of MAPKs and AP-1 in activated macrophages.
  • To elucidate the molecular mechanisms underlying vasopressin's anti-inflammatory effects.

Main Methods:

  • Murine macrophages (RAW264.7 cells) were stimulated with lipopolysaccharide (LPS) alone or with LPS plus vasopressin.
  • Cells were harvested at various time points (0-60 minutes) for analysis of MAPKs (ERK, JNK, p38) and AP-1 expression.
  • Immunoblotting and immunohistochemistry assays were employed to quantify protein and signal expressions.

Main Results:

  • Vasopressin significantly reduced extracellular regulated kinase (ERK) levels at 45 and 60 minutes post-LPS stimulation.
  • C-Jun N-terminal kinase (JNK) concentrations were significantly decreased by vasopressin at all measured time points (15-60 minutes).
  • p38 MAPK levels were significantly lower in the vasopressin-treated group at 15, 30, and 45 minutes, and AP-1 signals were weaker.

Conclusions:

  • Vasopressin demonstrates an inhibitory effect on MAPKs and AP-1 pathways in macrophages activated by endotoxin.
  • These findings highlight vasopressin as a potential therapeutic agent for inflammatory conditions mediated by these pathways.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
14.0K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.3K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
19.5K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.9K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.4K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
9.3K